Skip to main content
Clinical Trials/DRKS00031324
DRKS00031324
Not yet recruiting
Phase 2

Single-joint hybrid assistive limb as a new therapeutic device for active-assistive muscle activity-guided rehabilitation of knee joint injury-a randomized controlled clinical trial.

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Primary knee TEPFractures near the knee jointKnee ligaments/tendon injuries
Sponsor
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH
Enrollment
120
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 28, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • implantation of primary knee TEP, performance of KSR or BGSW
  • \-Surgery after fractures close to the knee joint, KSR or BGSW performed
  • \-Surgery after knee ligament/tendon injuries, performance of KSR or BGSW

Exclusion Criteria

  • \-American Society of Anesthesiologists (ASA)\-Score \> III (classification
  • for the physical status of the patient)
  • \-Neurological deficits
  • \-Patients with pacemakers
  • \-Skin diseases that are aggravated by sticking of the electrodes
  • \-Extensive edema of the lower extremity
  • \-patients with severe pain that makes conventional rehabilitation impossible
  • rehabilitation impossible
  • \-Rejection by patients

Outcomes

Primary Outcomes

Not specified

Similar Trials